Last reviewed · How we verify

NCT04726618

Development of Hardware and Software for Pulmonary Magnetic Resonance Imaging Using Inhaled Tracer Gases

Terminated Last updated 4 September 2025
What this trial tests

trial testing Hyperpolarized 129-xenon gas and Perfluoropropane gas in Healthy Volunteers in 24 participants. Terminated before completion.

Timeline
1 March 2022
Primary endpoint
9 April 2024
9 April 2024

Quick facts

Lead sponsorThe Hospital for Sick Children
StatusTerminated
Study typeOBSERVATIONAL
Enrollment24
Start date1 March 2022
Primary completion9 April 2024
Estimated completion9 April 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

The Hospital for Sick Children

Who can join

Adults 6 to 75, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single centre study. The overarching hypothesis of this study is that MRI with inhaled tracer gases can provide high quality images of lung function to complement conventional 1H MRI. The study interventions do not affect the standard of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other The Hospital for Sick Children trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04726618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing